June 19, 2019
Granite Creek Capital Partners, L.L.C. Announces an Investment in Royal Biologics (Globe Newswire)
Granite Creek Capital Partners, L.L.C., a private investment firm based in Chicago, today announces its investment in Royal Biologics, a medical device company focused on the growing regenerative medicine sector. The company, a leading manufacturer and distributor of devices used in stem cell and other surgical procedures, develops, licenses, produces and distributes biologics, orthobiologics and orthopedic implant products. Royal is the first healthcare investment of Granite Creek’s FlexCap II private investment fund.